MedPath

Effects of taurine in diabetic foot ulcer

Phase 3
Recruiting
Conditions
Diabetic Foot Ulcer.
Diabetic ulcer
E10, E11
Registration Number
IRCT20180514039657N2
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Diabetic foot ulcer grade 3 based on Wagner-Meggitt's benchmark
More than 5 years of illness
Patients with type 2 diabetes

Exclusion Criteria

The use of alternative therapies, including hormones or vitamin supplements
Pregnant or lactating women
Chronic kidney disease
Chronic liver disease
Chronic Pulmonary Disease
Chronic or acute inflammatory diseases
Heart valve disease
Short Bowel Syndrome
Allergy
Patients with low immune system (autoimmune)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath